SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-18-008654
Filing Date
2018-06-14
Accepted
2018-06-14 09:13:30
Documents
3
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm 10-K/A 178266
2 ex31-1.htm EX-31.1 6180
3 ex31-2.htm EX-31.2 6153
  Complete submission text file 0001493152-18-008654.txt   191636
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38022 | Film No.: 18898297
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences